Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterisation of antibody-binding RNAs selected from structurally constrained libraries

J Hamm1

  • 1Istituto di Ricerche di Biologia Molecolare, Roma, Italy.

Nucleic Acids Research
|June 15, 1996
PubMed
Summary

Researchers selected RNA molecules that bind to an antibody's antigen-binding site. Structurally constrained RNA molecules were found to bind tightly and specifically, demonstrating that constraints do not hinder effective RNA selection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoimmune pancreatitis-New evidence for clinical management strategies.

United European gastroenterology journal·2024
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy.

Current oncology (Toronto, Ont.)·2019
Same author

Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Surgeon Volume, Patient Age, and Tumor-Related Factors Influence the Need for Re-Excision After Breast-Conserving Surgery.

Annals of surgical oncology·2016

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Immunology

Background:

  • Antibody-antigen interactions are crucial in biological systems.
  • RNA molecules can be engineered to bind specific targets, offering therapeutic and diagnostic potential.
  • Selecting functional RNA molecules often involves complex libraries and selection cycles.

Purpose of the Study:

  • To select RNA molecules that bind to the antigen-binding site of an anti-ferritin antibody.
  • To investigate the impact of structural constraints on RNA selection and binding affinity.
  • To characterize the dynamic and conformational aspects of RNA-antibody interactions.

Main Methods:

  • Construction of constrained RNA libraries with limited sequence complexity.
  • Selection of RNA molecules using primer-binding sites with predictable secondary structures.

Related Experiment Videos

  • Real-time interaction analysis to study binding dynamics.
  • Circular dichroism spectroscopy to detect conformational changes.
  • Binding site sequestering assays to confirm target competition.

    • Main Results:

    • Successfully selected RNA molecules that bind to the anti-ferritin antibody's antigen-binding site.
    • Selected RNA molecules demonstrated competition with ferritin for binding, confirming specificity.
    • Introduction of strong structural constraints did not impede the selection of tightly and specifically binding RNAs.
    • Characterization of selected RNA secondary structures was facilitated by predictable primer-binding site structures.

    Conclusions:

    • Constrained RNA libraries can be effectively used to select high-affinity, specific RNA binders.
    • Structural constraints in RNA library design can aid in characterization without compromising binding capability.
    • This approach offers a viable strategy for developing RNA-based molecules for antibody targeting.